This local effect could be further stimulated by the additional modification of PD-1-CD28-expressing CAR or TRuC T cells with a chemokine receptor that enhances the accumulation of the engineered T cells in the tumor tissue [1, 11, 44, 45]. This evidence concerns the gene CD28 and neoplasm.